David K. Boston Partner MAIN OFFICE: New York Willkie Farr & Gallagher LLP 787 Seventh Avenue New York, N.Y. 10019-6099, U.S.A. T 212-728-8625 F 212-728-9625

David K. Boston is a partner in the Corporate and Financial Services Department and Co-Chair of the Capital Markets Practice Group of Willkie Farr & Gallagher LLP in New York.  Mr. Boston provides general corporate advice to both public and private companies and concentrates on mergers and acquisitions, public offerings and Rule 144A offerings of debt and equity securities, and private equity investments.

Chambers USA (2008) ranks Mr. Boston among the leading individuals practicing corporate/M&A law in New York.

In the area of mergers and acquisitions, Mr. Boston recently represented:  Level 3 Communications in its acquisitions of  Broadwing Corporation, TelCove, Inc. and WilTel Communications; Marsh Inc. in its sale of Crump Group, Inc. to an affiliate of J.C. Flowers & Co.; Cadmus Communications Corporation in its sale to Cenveo, Inc.;  The Titan Corporation in its merger with L-3 Communications; Neuberger Berman Inc. in its merger with Lehman Brothers Holdings and its acquisition of a number of privately held money management firms; América Móvil in its acquisition from Verizon of Telecomunicaciones de Puerto Rico; a joint venture of América Móvil and Teléfonos de Mexico in the venture’s proposed acquisition of Verizon’s interest in CANTV; Teléfonos de Mexico in its acquisition of the assets of AT&T Latin America, its acquisition of MCI’s controlling interest in Embratel Participacoes and the sale of its equity interest in MCI to Verizon; Securitas AB in its acquisition of Pinkerton's, Inc.; Warburg Pincus in its acquisition of TransDigm Holding Company and its acquisition of Centennial HealthCare Corporation; Xomed Surgical Products, Inc. in its sale to Medtronic, Inc.; Unilab Corporation in its sale to Kelso & Company; People's Choice Television Corp. in its sale to Sprint Corporation; Peter Kiewit Sons’, Inc. in its spin-off of Kiewit Materials Company; and Kiewit Materials Company in its sale to Rinker Materials Corporation.

In the area of public and private offerings, Mr. Boston has represented: Level 3 Communications, Inc. in offerings of senior notes, senior discount notes, convertible notes and common stock; Telcordia Technologies, Inc. in an offering of senior subordinated notes; Ventas, Inc. in offerings of senior notes, convertible notes and common stock; Martin Marietta Materials in an offering of senior notes; Xomed Surgical Products, Inc. in its initial public offering and follow-on equity offering; Spear, Leeds & Kellogg, L.P. in an offering of senior notes; Neuberger Berman Inc. in secondary equity offerings and an offering of convertible notes; Deutsche Bank Securities and its predecessors in the initial public offerings of MedCath Corporation and Transition Systems, Inc., follow-on equity offerings of Strategic Hotel & Resorts., Coeur D'Alene Mines Corporation, Albany Molecular Research, Inc. and Inspire Pharmaceuticals, Inc., and various debt offerings by Lennar Corporation and LNR Property Corporation; Citigroup in follow-on equity offerings of PartnerRe Ltd; and Credit Suisse and Piper Jaffray in a convertible notes offering and a follow-on equity offering of Integra LifeSciences.